OneSource Specialty Pharma informs about press release
OneSource Specialty Pharma has informed that it enclosed Press Release issued by the Company titled: OneSource Supports Second Generic Semaglutide Approval in Canada Enables commercialisation for the first two entrants in the world’s second-largest semaglutide market.
The above information is a part of company’s filings submitted to BSE.
